Patents-Review.com
🔗 Permalink
Assignee profile:

Syn X Pharma, Inc.

City:

Ontario

Country:

Canada

Published Applications:

16

Last publication date:

2006-11-07

Patent Grants:

16

Last grant date:

2006-11-07

Top Inventors for applications by Syn X Pharma, Inc.

These are the the leading inventors for applications assigned to Syn X Pharma, Inc.:

Recent patent applications by Syn X Pharma, Inc.

Syn X Pharma, Inc. based in Ontario, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2006-11-07 ✅ Patent 7,132,244 granted on 2006-11-07
US9992067
-

Betaine/GABA transport protein biopolymer marker indicative of insulin resistance

 #2 | 2006-09-05 ✅ Patent 7,101,680 granted on 2006-09-05
US9971740
-

Method for detecting the presence of monomeric brain associated human glutamine synthetase

 #3 | 2006-08-08 ✅ Patent 7,087,435 granted on 2006-08-08
US9846328
-

Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons

 #4 | 2006-07-20 ✅ Patent 7,179,606 granted on 2007-02-20
US20060160233A1
Chemistry; metallurgy

IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease

 #5 | 2006-07-20 ✅ Patent 7,097,989 granted on 2006-08-29
US20060160232A1
Physics

Complement C3 precursor biopolymer markers predictive of type II diabetes

 #6 | 2006-07-11 ✅ Patent 7,074,576 granted on 2006-07-11
US9992672
-

Protein biopolymer markers indicative of alzheimer's disease

 #7 | 2006-07-04 ✅ Patent 7,070,945 granted on 2006-07-04
US10246383
-

Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment

 #8 | 2006-05-30 ✅ Patent 7,052,849 granted on 2006-05-30
US9991627
-

Protein biopolymer markers predictive of insulin resistance

 #9 | 2006-05-23 ✅ Patent 7,049,397 granted on 2006-05-23
US9845731
-

Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons

 #10 | 2006-04-11 ✅ Patent 7,026,129 granted on 2006-04-11
US9991797
-

IG lambda biopolymer markers predictive of Alzheimers disease

 #11 | 2006-03-21 ✅ Patent 7,014,854 granted on 2006-03-21
US10334701
-

Method for retarding or precluding Alzheimer's dementia

 #12 | 2006-03-09 ✅ Patent 7,094,549 granted on 2006-08-22
US20060051877A1
Chemistry; metallurgy

Fibronectin biopolymer marker indicative of insulin resistance

 #13 | 2006-02-14 ✅ Patent 6,998,243 granted on 2006-02-14
US9845739
-

Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons

 #14 | 2005-05-10 ✅ Patent 6,891,154 granted on 2005-05-10
US10231660
-

Amino acid sequence pattern matching

 #15 | 2005-05-10 ✅ Patent 6,890,722 granted on 2005-05-10
US9991800
-

HP biopolymer markers predictive of insulin resistance

 #16 | 2005-05-10 ✅ Patent 6,890,763 granted on 2005-05-10
US9845729
-

Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons
AssigneeID:

366352 ⎘